PharmaLive.com's e-marketing newsletter
If you are having problems viewing this message, use this link
 
PharmaLive.com e-marketing newsletter
 
 

Today's Headlines
> HeartWare Receives FDA Approval for HeartWare Ventricular Assist System
> NeuViz 64 Multi-slice CT Scanner from Neusoft Medical Systems Receives FDA Clearance
> TomTec Receives FDA 510(K) Clearance for Its Image-Com 5.0 Software
> Vitacon Receives FDA 510(k) Clearance
> Teleflex Receives FDA 510(k) Clearance for Nylus PICC with Semprus Sustain Technology
> Phenox Receives CE Mark Approval for P64 Flow Modulation Device
 
Headline Sponsor
Med Ad News is your source for key performance metrics and extensive analytical reporting including Top Biotechnology Companies, Top Medicines, and Top Pharmaceutical Companies. Subscribe now to SAVE 30% and access this data at PharmaLive.com plus other valuable benefits, click here.
 
HeartWare Receives FDA Approval for HeartWare Ventricular Assist System
HeartWare International announced that it has received approval from the FDA for the HeartWare Ventricular Assist System as a bridge to heart transplantation in patients with end-stage heart failure. Read More
NeuViz 64 Multi-slice CT Scanner from Neusoft Medical Systems Receives FDA Clearance
Neusoft Medical Systems Co. announced that the NeuViz 64 multi-slice CT scanner has received FDA 510k clearance. Read More
TomTec Receives FDA 510(K) Clearance for Its Image-Com 5.0 Software
TomTec Imaging Systems GmbH announces the FDA 510(k) clearance for its new Image-Com 5 software solution. Read More
Vitacon Receives FDA 510(k) Clearance
Vitacon announced it has received FDA clearance on its VitaScan LT USB bladder scanner. Read More
Teleflex Receives FDA 510(k) Clearance for Nylus PICC with Semprus Sustain Technology
Teleflex Incorporated announced that its Semprus BioSciences subsidiary has been granted 510(k) clearance for the company's vascular access catheter, the Nylus Peripherally Inserted Central Catheter with Semprus Sustain Technology. Read More
Phenox Receives CE Mark Approval for P64 Flow Modulation Device
Phenox GmbH announced the p64 Flow Modulation Device has been granted CE Mark approval. The p64 Flow Modulation Device is an intraluminal flow diverter intended to treat complex intracranial aneurysms and dissections. Read More
 
 November 29, 2012
Refer a Colleague
Share this information
with a colleague or friend.
 

Follow us on Twitter

twitter.com/ChristianeTrue for Editor-in-Chief Christiane Truelove's insights on pharma news, PR initiatives, and social media

twitter.com/MedAdNews for Med Ad News news updates, exclusive content, and insights from the editors of Med Ad News

twitter.com/PharmaLive for breaking news
     

If you feel you have received this message in error, or wish to unsubscribe from this newsletter only, please REMOVE ME.

Click here to view UBM Canon's privacy policy.


UBM Canon * 300 American Metro Blvd., Suite 125, Hamilton, NJ 08619 * United States * +1-609-759-7600